A recent paper suggests that TGFβ neutralization targets only selected CAF subtypes and, in turn, promotes CAF immunomodulatory properties and the formation of an immune-permissive tumor microenvironment (TME) by regulating ECM density [82]. Here, TGFB1 is linked to neoplasm.